HYPD
Price
$10.74
Change
-$0.82 (-7.09%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
55.08M
QNTM
Price
$16.98
Change
-$0.43 (-2.47%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
57.6M
Interact to see
Advertisement

HYPD vs QNTM

Header iconHYPD vs QNTM Comparison
Open Charts HYPD vs QNTMBanner chart's image
Hyperion DeFi
Price$10.74
Change-$0.82 (-7.09%)
Volume$2.62K
Capitalization55.08M
Quantum Biopharma
Price$16.98
Change-$0.43 (-2.47%)
Volume$1.04K
Capitalization57.6M
HYPD vs QNTM Comparison Chart in %
Loading...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPD vs. QNTM commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPD is a Hold and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (HYPD: $11.56 vs. QNTM: $17.41)
Brand notoriety: HYPD and QNTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HYPD: 13% vs. QNTM: 88%
Market capitalization -- HYPD: $55.08M vs. QNTM: $57.6M
HYPD [@Biotechnology] is valued at $55.08M. QNTM’s [@Biotechnology] market capitalization is $57.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPD’s FA Score shows that 0 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • HYPD’s FA Score: 0 green, 5 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, HYPD is a better buy in the long-term than QNTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPD’s TA Score shows that 2 TA indicator(s) are bullish while QNTM’s TA Score has 3 bullish TA indicator(s).

  • HYPD’s TA Score: 2 bullish, 4 bearish.
  • QNTM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both HYPD and QNTM are a bad buy in the short-term.

Price Growth

HYPD (@Biotechnology) experienced а +9.47% price change this week, while QNTM (@Biotechnology) price change was -14.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.91%. For the same industry, the average monthly price growth was +17.27%, and the average quarterly price growth was +18.94%.

Reported Earning Dates

QNTM is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+12.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNTM($57.6M) and HYPD($55.1M) have the same market capitalization . HYPD YTD gains are higher at: 7817.809 vs. QNTM (357.880). QNTM has higher annual earnings (EBITDA): -20.68M vs. HYPD (-39.11M). HYPD has higher revenues than QNTM: HYPD (67.1K) vs QNTM (0).
HYPDQNTMHYPD / QNTM
Capitalization55.1M57.6M96%
EBITDA-39.11M-20.68M189%
Gain YTD7817.809357.8802,184%
P/E RatioN/AN/A-
Revenue67.1K0-
Total CashN/A3.54M-
Total DebtN/A1.28M-
FUNDAMENTALS RATINGS
HYPD vs QNTM: Fundamental Ratings
HYPD
QNTM
OUTLOOK RATING
1..100
3277
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
36100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPD's Valuation (53) in the Pharmaceuticals Major industry is in the same range as QNTM (71) in the null industry. This means that HYPD’s stock grew similarly to QNTM’s over the last 12 months.

HYPD's Profit vs Risk Rating (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for QNTM (100) in the null industry. This means that HYPD’s stock grew somewhat faster than QNTM’s over the last 12 months.

HYPD's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as QNTM (100) in the null industry. This means that HYPD’s stock grew similarly to QNTM’s over the last 12 months.

HYPD's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as QNTM (34) in the null industry. This means that HYPD’s stock grew similarly to QNTM’s over the last 12 months.

HYPD's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as QNTM (100) in the null industry. This means that HYPD’s stock grew similarly to QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HYPDQNTM
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 20 days ago
83%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NORSF0.200.03
+16.22%
NORSK TITANIUM AS
STBK10.00N/A
N/A
Studio Financial Holdings, Inc.
SMSMY10.41N/A
N/A
Sims Ltd
SEOJF8.56N/A
N/A
Stora Enso Oyj
ASAPF0.22N/A
N/A
Aurora Spine Corp

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with CTXR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
+1.58%
CTXR - HYPD
37%
Loosely correlated
-8.08%
QNTM - HYPD
35%
Loosely correlated
+5.13%
INKT - HYPD
34%
Loosely correlated
+2.71%
VACBF - HYPD
32%
Poorly correlated
N/A
ACXP - HYPD
30%
Poorly correlated
+3.63%
More

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
+1.75%
HYPD - QNTM
35%
Loosely correlated
-6.66%
CPIX - QNTM
26%
Poorly correlated
+0.49%
EBS - QNTM
24%
Poorly correlated
+6.70%
RNA - QNTM
24%
Poorly correlated
+6.91%
PBH - QNTM
24%
Poorly correlated
+0.31%
More